Anthony J. Windebank

Anthony J. Windebank, M.D., is a Professor of Neurology at Mayo Clinic in Rochester, Minnesota, affiliated with the Mayo Clinic College of Medicine and Science. He serves as a Consultant in the Department of Neurology and holds leadership in faculty development. His research is centered at the Regenerative Neurobiology Laboratory, with collaborative ties to the Mayo Clinic Comprehensive Cancer Center, Neurosurgery, Orthopedic Surgery, and Biochemistry departments.

• University: Mayo Clinic
• School: Mayo Clinic College of Medicine and Science
• Department: Department of Neurology
• Academic Rank: Professor

Dr. Windebank's research focuses on understanding the cellular mechanisms of neuronal death and regeneration in the nervous system. His work spans spinal cord injury, peripheral nerve repair, amyotrophic lateral sclerosis (ALS), and chemotherapy-induced peripheral neuropathy. He utilizes cellular, Drosophila, and rodent models to explore regenerative strategies and translate findings into clinical applications through tissue and cell engineering.

His recent publications highlight a strong trend in regenerative neurology, including stem cell therapies for spinal cord injury and ALS, mitochondrial function in neurodegeneration, and exosome-based interventions. These works reflect interdisciplinary efforts combining molecular biology, translational medicine, and clinical neurology.

• Chemotherapy-Induced Peripheral Neuropathy
• Spinal Cord Injury and Repair
• Neural Stem Cell Regeneration
• Mitochondrial Dysfunction in Neurodegeneration
• Regulatory Science in Regenerative Medicine
• Neuroprotective Growth Factors

Dr. Windebank has received numerous scientific honors, including the Judith and Jean Pape Adams Charitable Foundation Professorship (2019), an honorary doctorate from Paracelsus Medical University (2010), and the E.T.S. Walton Fellowship (2005). He is also recognized for teaching excellence, having received multiple Teacher of the Year awards and the Distinguished Educator award from Mayo Clinic.

He has led major research grants from the National Institutes of Health (NIA, NIBIB, NINDS) and the National Center for Advancing Translational Sciences, supporting projects such as biodegradable polymer implants for spinal cord repair and neuroprotective strategies using IGF-1. He has mentored postdoctoral researchers, medical students, and graduate students, and has held leadership roles in education and research policy at Mayo Clinic.

Dr. Windebank is actively involved in professional societies including the Peripheral Nerve Society, American Academy of Neurology, and Society for Neuroscience, and has served on advisory boards for the ALS Association and the Neuropathy Association.